Calidi Biotherapeutics to present CLD-401 data and TCE platform advances at ESMO 2026
The company says it will present new CLD-401 data and advances in its in situ TCE platform at the ESMO Congress 2026.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.